Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack-Reference-Cited by-同舟云学术

Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack

Published:2019-10-09 Issue:10 Volume:2019 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Liu Jia¹,Wang Lu-Ning²

Affiliation:

1. Xuanwu Hospital, Capital Medical University; Department of Neurology; Changchun Street 45 Beijing China 100053

2. Chinese PLA General Hospital; Department of Geriatric Neurology; Fuxing Road 28 Haidian District Beijing China 100853

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010693.pub5/epdf/full

Reference60 articles.

1. Pioglitazone prevents diabetes in patients with insulin resistance and cerebrovascular disease;Inzucchi;Diabetes Care,2016

2. Pioglitazone after ischemic stroke or transient ischemic attack;Kernan;New England Journal of Medicine,2016

3. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial;Viscoli;American Heart Journal,2014

4. Effects of pioglitazone in patients with impaired glucose tolerance after stroke; progress report from J-SPIRIT study;Tanaka;International Journal of Stroke,2010

5. Effects of pioglitazone in patients with abnormal glucose metabolism after stroke. The J-SPIRIT study;Tanaka;Stroke,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Huangma Ding or autologous platelet-rich gel for the diabetic lower extremity arterial disease patients with foot ulcers;World Journal of Diabetes;2024-05-15

2. Thiazolidinediones Decrease the Recurrence of Intracerebral Hemorrhage in Type 2 Diabetes Mellitus Patients: A Nested Case-Control Study;Neuroepidemiology;2024-05-03

3. Therapeutic management of metabolic dysfunction associated steatotic liver disease;United European Gastroenterology Journal;2024-01-09

4. Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis;Gut;2023-11-09

5. Secondary Ischemic Stroke Prevention;Neurotherapeutics;2023-04